From: Antineoplastic effect of iodine in mammary cancer: participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR)
Treatment
Body weight gain (g)
T3 (ng/dl)
Control
154 ± 15
63.7 ± 10
MNU
157 ± 12
67.9 ± 3
Control + I2
152 ± 9
63.2 ± 11
MNU + I2
150 ± 16
60.2 ± 5.6